Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05112198 · ClinicalTrials.gov registry record · NA
Digital Symptom Tracking, Patient Engagement and Quality of Life in Advanced Cancer
A NA study of Quality of Life, sponsored by Stanford University.
- Active
- Registry status
- NA
- Development phase
- 41
- Enrollment target
- 2
- Study locations
NCT05112198: Active NA study of Quality of Life, sponsored by Stanford University.
NCT05112198 is a NA study of Quality of Life that is active but no longer recruiting, run by Stanford University. The registered enrollment target is 41 participants, below the 452-participant average among 107 other Quality of Life trials with a reported enrollment target (91% lower). The trial reports 2 study locations across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05112198, a NA study of Quality of Life, is active but no longer recruiting, sponsored by Stanford University.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 41 participants
- Enrollment target
- 2
- Study locations
Study Summary
The purpose of this study is to (1) describe patient and clinician engagement in web-based symptom self-monitoring, (2) identify differences in symptom management between intervention and usual care groups, and (3) identify potential outcomes of real-time symptom tracking and management. With the assistance of the study coordinator, participants randomized to the intervention will create an account with Noona. Patients will be instructed to log symptoms as often as relevant using their own personal devices. Patients will also be prompted once per week for 24 weeks to log any recent symptoms. These participants will be sent a Symptom Questionnaire (SQ) via the Noona tool that summarizes their symptoms and distress one week prior to each oncology clinic visit. Symptoms designated as clinically severe either during regular symptom logging or via the SQ will trigger a prompt to contact the clinical team for immediate follow-up.
Conditions Studied
Interventions
- DEVICE Use of Noona web- based symptom tracking tool
Study Locations (2)
California
- Stanford Cancer Institute - Palo Alto
- UCSF Helen Diller Medical Center - San Francisco
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 41 participants |
| Start Date | 2018-03-01 |
| Est. Completion | 2025-09 |
| Phase | NA |
What the registry record for NCT05112198 still lists
NCT05112198 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 41 participants, a relatively small participant target, below the 452-participant average among 107 other Quality of Life trials with a reported enrollment target (91% lower).
The record links to 1 condition, with Quality of Life appearing as the primary indexed condition, and to 1 intervention - of which Use of Noona web- based symptom tracking tool is the first listed.
NCT05112198 reports a single indexed study location in California.
Frequently Asked Questions
What is clinical trial NCT05112198 about?
NCT05112198 is a clinical study titled "Digital Symptom Tracking, Patient Engagement and Quality of Life in Advanced Cancer". The purpose of this study is to (1) describe patient and clinician engagement in web-based symptom self-monitoring, (2) identify differences in symptom management between intervention and usual care groups, and (3) identify potential outcomes of real-time symptom tracking and management. With the a...
What is the current status of trial NCT05112198?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 41 participants. The study started on 2018-03-01. Estimated completion is 2025-09.
What conditions does trial NCT05112198 study?
This clinical trial studies the following conditions: Quality of Life.
What interventions are being tested in trial NCT05112198?
The interventions under investigation include: Use of Noona web- based symptom tracking tool (DEVICE).
Who is sponsoring clinical trial NCT05112198?
This trial is sponsored by Stanford University, which has 1,744 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05112198 being conducted?
This trial has 2 study locations across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Quality of Life
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05112198's enrollment target sits among peer trials
41 83rd of 107 higher than 25 of 107 other Quality of Life trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Quality of Life trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Impact of Positive Airway Pressure Therapy on Clinical Outcomes in Older Veterans With Chronic Obstructive Pulmonary Disease and Comorbid Obstructive Sleep Apnea (Overlap Syndrome)
RECRUITING · NA
-
Development of a Multi-sensory Rehabilitation Program for People With Ultra Low Vision
RECRUITING · NA
-
Exploring Virtual Reality Adventure Training Exergaming
RECRUITING · NA
-
Therapeutic Plantar Electrical Stimulation Intervention During Hemodialysis to Improve Balance and Mobility
RECRUITING · NA
-
Trajectories of Recovery After Intravenous Propofol Versus Inhaled VolatilE Anesthesia Trial
RECRUITING · NA
-
Asthma Intervention With Residential Ventilation and Air Cleaner (AIRVAC) Study
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03449238 · 41 participants · Phase 1
Pembrolizumab And Stereotactic Radiosurgery (Srs) Of Selected Brain Metastases In Breast Cancer Patients
- NCT03900793 · 41 participants · Phase 1
Losartan + Sunitinib in Treatment of Osteosarcoma
- NCT04082520 · 41 participants · Phase 2
Lutathera for the Treatment of Inoperable, Progressive Meningioma After External Beam Radiation Therapy
- NCT04220190 · 41 participants · Phase 2
RAPA-501 Therapy for ALS
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI